Factors Affecting Postoperative Lung Expansion in Patients with Pyogenic Empyema

Abstract

Background In patients with parapneumonic empyema, decortication is usually preferred to ensure functional lung re-expansion. However, there could be patients exhibiting incomplete postoperative lung expansion and inadequate drainage despite decortication. Therefore, we evaluated factors affecting postoperative lung expansion in patients undergoing decortication.

Methods A total of 221 patients with pyogenic empyema who underwent video-assisted thoracoscopic surgery (VATS) between January and October 2016 in our hospital were reviewed in terms of surgical success. The following factors were evaluated: age; the time between identification of a localized effusion and surgical referral; chest tube drainage durations; any underlying morbidity preoperative blood culture data; and the thickness of the visceral pleura.

Results Several factors that significantly prolonged the postoperative time to lung expansion were evident in patients with diabetes mellitus (DM) and bacteremia; postoperative chest tube drainage was significantly longer in those with DM (p = 0.009) and bacteremia (p = 0.01); and postoperative hospitalization time was significantly longer in patients with bacteremia (p = 0.01). The thickness of the visceral pleura was strongly correlated with postoperative chest tube drainage duration and postoperative hospitalization time (Pearson correlation coefficient, r = 0.245, p = 0.00).

Conclusions In patients with DM, bacteremia, or thickened pleura, the time to lung expansion after operation was longer. Therefore, stricter pre- and post-operative control of blood-sugar levels and adequate antibiotics are required to facilitate postoperative lung re-expansion. In patients with thickened pleurae, prolonged chest tube placement is unavoidable.

Keywords

pleural space - pleural air leak/effusion - thoracoscopy/VATS

• References

• 1 Ferreiro L, San José ME, Valdés L. Management of parapneumonic pleural effusion in adults. Arch Bronconeumol 2015; 51 (12) 637-646
• 2 Koppurapu V, Meena N. A review of the management of complex para-pneumonic effusion in adults. J Thorac Dis 2017; 9 (07) 2135-2141
• 3 Ohara G, Tamura T, Satoh H. Decortication of empyema. Ann Thorac Med 2016; 11 (03) 230-231
• 4 Bagheri R, Tavassoli A, Haghi SZ. , et al. The role of thoracoscopic debridement in the treatment of parapneumonic empyema. Asian Cardiovasc Thorac Ann 2013; 21 (04) 443-446
• 5 Martínez-Ferro M, Duarte S, Laje P. Single-port thoracoscopy for the treatment of pleural empyema in children. J Pediatr Surg 2004; 39 (08) 1194-1196
• 6 Bender MT, Ferraris VA, Saha SP. Modern management of thoracic empyema. South Med J 2015; 108 (01) 58-62
• 7 Hajjar WM, Ahmed I, Al-Nassar SA. , et al. Video-assisted thoracoscopic decortication for the management of late stage pleural empyema, is it feasible?. Ann Thorac Med 2016; 11 (01) 71-78
• 8 Tsai CH, Lai YC, Chang SC, Chang CY, Wang WS, Yuan MK. Video-assisted thoracoscopic surgical decortication in the elderly with thoracic empyema: five years' experience. J Chin Med Assoc 2016; 79 (01) 25-28
• 9 Tantraworasin A, Thepbunchonchai A, Siwachat S. , et al. Factors associated with recurrent bacterial empyema thoracis. Asian J Surg 2017; pii: S1015-9584(16)30498-5. doi: 10.1016
• 10 Noppen M. The utility of thoracoscopy in the diagnosis and management of pleural disease. Semin Respir Crit Care Med 2010; 31 (06) 751-759
• 11 Pan H, He J, Shen J, Jiang L, Liang W, He J. A meta-analysis of video-assisted thoracoscopic decortication versus open thoracotomy decortication for patients with empyema. J Thorac Dis 2017; 9 (07) 2006-2014
• 12 Casali C, Storelli ES, Di Prima E, Morandi U. Long-term functional results after surgical treatment of parapneumonic thoracic empyema. Interact Cardiovasc Thorac Surg 2009; 9 (01) 74-78
• 13 Rzyman W, Skokowski J, Romanowicz G, Lass P, Dziadziuszko R. Decortication in chronic pleural empyema – effect on lung function. Eur J Cardiothorac Surg 2002; 21 (03) 502-507
• 14 Patel GP, Balk RA. Systemic steroids in severe sepsis and septic shock. Am J Respir Crit Care Med 2012; 185 (02) 133-139
• 15 Salluh JI, Soares M, Póvoa P. Corticosteroids in severe community-acquired pneumonia: the path we choose depends on where we want to get. Crit Care 2011; 15 (02) 137
• 16 Ferrer R, Artigas A. Effectiveness of treatments for severe sepsis: data from the bundle implementation programs. Minerva Anestesiol 2011; 77 (03) 360-365